Thyroid cancer is widely considered the most curable cancer, with a 98.3% five-year survival rate across all stages. But it’s not alone at the top. Several cancers, when caught early, have survival rates above 90%, and some effectively reach 100% at localized stages. The answer depends partly on what “curable” means and partly on when the cancer is found.
What “Curable” Actually Means in Oncology
Doctors are cautious with the word “cure.” A cure means no traces of cancer remain and the disease will never return. In practice, most oncologists use the term “complete remission,” meaning all detectable signs of cancer have disappeared. If you stay in complete remission for five years or more, some doctors will call that a cure, but it’s never a guarantee. Cancer cells can remain dormant in the body for years, and most recurrences happen within that first five-year window. Beyond it, the risk drops substantially but never hits zero.
That’s why survival statistics use “five-year relative survival rate” as the standard benchmark. This number compares how likely a person with cancer is to be alive five years after diagnosis relative to someone without cancer. A rate of 99% means the cancer barely affects life expectancy at all.
The Cancers With the Highest Survival Rates
Based on data from the National Cancer Institute’s SEER program (covering diagnoses from 2016 to 2022), these cancers have five-year relative survival rates above 90%:
- Thyroid cancer: 98.3%
- Prostate cancer: 98.2%
- Melanoma (skin): 94.7%
- Testicular cancer: 94.6%
- Breast cancer: 91.9%
These numbers represent all stages combined. When you look only at cancers caught early, before they spread beyond the original site, several of these approach or reach 99 to 100%.
Thyroid Cancer: The Standout
Thyroid cancer earns the top spot because even its long-term numbers are exceptional. The most common form, papillary thyroid carcinoma, accounts for roughly 80% of all thyroid cancers. For small papillary tumors that haven’t spread to lymph nodes, the 20-year survival rate still exceeds 99%. Even when the cancer has reached nearby lymph nodes, 20-year survival remains above 95%.
Treatment is typically straightforward: surgical removal of part or all of the thyroid gland, sometimes followed by a radioactive iodine treatment that targets any remaining thyroid tissue. For very small tumors (under about 1 centimeter), some doctors now recommend active surveillance instead of immediate surgery. This means regular ultrasound monitoring, with surgery only if the tumor grows by 3 millimeters or more or if lymph node spread is detected. Many of these tiny cancers never progress at all.
After treatment, most people take a daily thyroid hormone pill for the rest of their lives, since the thyroid gland is either partially or fully removed. It’s a manageable trade-off for a cancer with near-perfect survival numbers.
Prostate Cancer: Near-Perfect Localized Survival
Localized prostate cancer, meaning cancer that hasn’t spread beyond the prostate gland, has a 10-year relative survival rate of 100%, according to CDC data covering 2001 through 2016. That’s as close to “cured” as cancer statistics get.
The catch is that treatment often comes with significant side effects. Surgery and radiation can cause long-term urinary incontinence and erectile dysfunction. Because localized prostate cancer grows slowly in many cases, some men opt for active surveillance rather than immediate treatment, monitoring the cancer with regular testing and only intervening if it shows signs of becoming more aggressive. Up to 6% of localized cases eventually progress to metastatic disease, so this is a decision made carefully with a doctor.
Melanoma: Early Detection Changes Everything
Melanoma shows the most dramatic difference between early and late detection of any cancer on this list. When caught at the localized stage, before it has penetrated deeply into the skin or spread, the five-year survival rate is above 99%. At that point, treatment is often just surgical removal of the affected skin and a margin of healthy tissue around it.
Once melanoma spreads to distant parts of the body, the picture changes significantly. That’s why dermatologists emphasize regular skin checks. A new or changing mole, an asymmetric spot, or a lesion with irregular borders or multiple colors warrants prompt evaluation. The difference between a localized melanoma and one that has reached lymph nodes or organs can come down to months of delay.
Testicular Cancer: Highly Curable Even When Advanced
Testicular cancer is unusual in that it maintains strong survival rates even after spreading. Localized testicular cancer has a 99% five-year survival rate. Regional spread (to nearby lymph nodes) drops only slightly, to 96%. Even distant spread, where the cancer has reached the lungs or other organs, still carries a 72% five-year survival rate, which is remarkably high for a metastatic cancer.
This resilience comes from testicular cancer’s exceptional sensitivity to chemotherapy. The cancer cells respond dramatically well to platinum-based treatment regimens. Most men diagnosed with testicular cancer are between 15 and 35, and the vast majority return to normal life after treatment. Fertility preservation before chemotherapy is a practical concern worth discussing early, since treatment can temporarily or permanently affect sperm production.
Hodgkin Lymphoma: A Blood Cancer Success Story
While it doesn’t appear in the top five survival-rate list, Hodgkin lymphoma deserves mention as one of the most curable cancers overall. Up to 90% of all newly diagnosed patients can be cured with chemotherapy, radiation, or both. Newer treatment combinations have pushed the six-year overall survival rate to nearly 94%.
Even patients whose cancer returns after initial treatment have strong options. More than half of people with recurrent Hodgkin lymphoma achieve long-term disease-free survival through additional therapy followed by a stem cell transplant. This is one of the few cancers where the word “cure” is used freely and frequently by oncologists.
Childhood Leukemia: A Dramatic Transformation
Acute lymphoblastic leukemia in children is perhaps the greatest success story in cancer treatment history. In 1975, the five-year survival rate for children under 15 was just 60%. Today it exceeds 90%, with about 85% of patients aged 1 to 18 expected to be long-term event-free survivors, meaning they remain cancer-free for years after completing treatment.
For adolescents aged 15 to 19, the improvement is even more striking. Their five-year survival climbed from 28% in 1975 to more than 75% today. Treatment typically involves an intensive chemotherapy protocol lasting two to three years, but the long-term outlook for most children is a full, normal life.
Why Stage Matters More Than Type
The single biggest factor in whether any cancer is “curable” isn’t which organ it starts in. It’s how early it’s found. A localized melanoma and a localized prostate cancer both have survival rates at or above 99%. A stage IV version of either one is a fundamentally different disease. The cancers that rank as “most curable” tend to share a few features: they’re often detected before spreading, they grow relatively slowly, or they respond exceptionally well to available treatments. Thyroid cancer checks all three boxes, which is why it consistently tops the list.